Simplex Trading’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $34M | Sell |
670,000
-1,064,500
| -61% | -$49.7M | 0.02% | 300 |
|
|
2025
Q4 | $51.2M | Buy |
1,734,500
+142,500
| +9% | +$3.87M | 0.03% | 287 |
|
|
2025
Q3 | $41.1M | Buy |
1,592,000
+627,800
| +65% | +$17.5M | 0.02% | 404 |
|
|
2025
Q2 | $26.6M | Sell |
964,200
-262,600
| -21% | -$6.92M | 0.02% | 460 |
|
|
2025
Q1 | $34.8M | Buy |
1,226,800
+339,900
| +38% | +$12.1M | 0.02% | 355 |
|
|
2024
Q4 | $36.9M | Buy |
886,900
+200,200
| +29% | +$9.57M | 0.02% | 394 |
|
|
2024
Q3 | $45.9M | Sell |
686,700
-2,800
| -0.4% | -$257K | 0.03% | 323 |
|
|
2024
Q2 | $81.9M | Sell |
689,500
-37,800
| -5% | -$4.78M | 0.05% | 190 |
|
|
2024
Q1 | $77.5M | Sell |
727,300
-189,200
| -21% | -$19.1M | 0.04% | 228 |
|
|
2023
Q4 | $91.1M | Buy |
916,500
+15,400
| +2% | +$1.3M | 0.06% | 196 |
|
|
2023
Q3 | $93.1M | Buy |
901,100
+506,500
| +128% | +$56.5M | 0.07% | 148 |
|
|
2023
Q2 | $47.9M | Sell |
394,600
-588,000
| -60% | -$78.4M | 0.04% | 280 |
|
|
2023
Q1 | $151M | Buy |
982,600
+348,000
| +55% | +$57.4M | 0.13% | 96 |
|
|
2022
Q4 | $97M | Buy |
634,600
+269,600
| +74% | +$44.1M | 0.11% | 146 |
|
|
2022
Q3 | $43.2M | Sell |
365,000
-187,300
| -34% | -$28.4M | 0.05% | 279 |
|
|
2022
Q2 | $78.9M | Sell |
552,300
-241,800
| -30% | -$34.6M | 0.08% | 152 |
|
|
2022
Q1 | $137M | Sell |
794,100
-98,200
| -11% | -$16.5M | 0.13% | 108 |
|
|
2021
Q4 | $227M | Buy |
892,300
+459,900
| +106% | +$134M | 0.23% | 61 |
|
|
2021
Q3 | $102M | Buy |
432,400
+10,500
| +2% | +$3.87M | 0.09% | 143 |
|
|
2021
Q2 | $99.1M | Buy |
421,900
+418,431
| +12,062% | +$74.8M | 0.1% | 140 |
|
|
2021
Q1 | $45.4M | Sell |
3,469
-809
| -19% | -$117K | 0.08% | 143 |
|
|
2020
Q4 | $44.7M | Buy |
+4,278
| New | +$433K | 0.06% | 189 |
|
|
2020
Q3 | – | Sell |
-4,354
| Closed | -$28M | – | 8205 |
|
|
2020
Q2 | $28M | Buy |
4,354
+3,024
| +227% | +$166K | 0.04% | 238 |
|
|
2020
Q1 | $3.98M | Buy |
1,330
+917
| +222% | +$21.1K | 0.01% | 817 |
|
|
2019
Q4 | $807K | Sell |
413
-189
| -31% | -$3.35K | ﹤0.01% | 2284 |
|
|
2019
Q3 | $958K | Buy |
602
+414
| +220% | +$6.12K | ﹤0.01% | 1969 |
|
|
2019
Q2 | $275K | Sell |
188
-158
| -46% | -$3.39K | ﹤0.01% | 3161 |
|
|
2019
Q1 | $704K | Buy |
346
+345
| +34,500% | +$6.4K | ﹤0.01% | 2295 |
|
|
2018
Q4 | $1K | Buy |
+1
| New | +$16 | ﹤0.01% | 6764 |
|
Other funds holding MRNA
VCM
VPM
Simplex Trading's MRNA Position: Q1 2026 in Review
Simplex Trading increased its Moderna (MRNA) stake by 145% in Q1 2026, buying an estimated $6.06M and bringing the position to 219,573 shares worth $11.2M. The position accounts for 0.01% of the portfolio, ranked #655.
Simplex Trading first reported a position in MRNA in Q4 2018 and has held it in 24 quarters since. The position peaked at $12.7M in Q1 2022. 722 funds tracked by Wall St. Rank hold MRNA as of Q1 2026.
- Simplex Trading held 219,573 shares of Moderna worth $11.2M as of Q1 2026.
- Simplex Trading bought 129,897 Moderna shares in Q1 2026, an estimated $6.06M.
- Moderna made up 0.01% of Simplex Trading's portfolio in Q1 2026, its #655 holding.
- Simplex Trading first reported a position in Moderna in Q4 2018 and has held it in 24 quarters since.
- Simplex Trading's Moderna position peaked at $12.7M in Q1 2022.
- 722 funds tracked by Wall St. Rank held Moderna as of Q1 2026.
Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.